Cargando…

Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis

BACKGROUND: In juvenile idiopathic arthritis (JIA) clinical remission is unattainable in some patients despite modern biologic disease-modifying antirheumatic drugs (bDMARD) therapy and switching bDMARD is required. The best choice of second-line bDMARD remains unclear. This retrospective observatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedersen, Mia Lindegaard, Neve-Græsbøll, Amalie, Herlin, Troels, Glerup, Mia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518086/ https://www.ncbi.nlm.nih.gov/pubmed/37742033 http://dx.doi.org/10.1186/s12969-023-00897-6

Ejemplares similares

Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children
por: Brix, Ninna, et al.
Publicado: (2020)

Initial radiological signs of dentofacial deformity in juvenile idiopathic arthritis
por: Stoustrup, Peter, et al.
Publicado: (2021)

Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience
por: Høeg, Pia Elkjær, et al.
Publicado: (2022)

Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
por: Mikola, Katriina, et al.
Publicado: (2022)

Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment
por: Lomholt, Johanne Jeppesen, et al.
Publicado: (2013)

The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Nielsen, Susan, et al.
Publicado: (2018)

M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
por: Brix, Ninna, et al.
Publicado: (2022)

Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis
por: Herlin, Troels
Publicado: (2010)

Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study
por: Rypdal, Veronika, et al.
Publicado: (2018)

Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2019)

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1—results of the Canadian model in the Nordic cohort
por: Rypdal, Veronika, et al.
Publicado: (2019)

Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis
por: Niu, Xiaowen, et al.
Publicado: (2022)

Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
por: Glerup, Mia, et al.
Publicado: (2019)

Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort
por: Arnstad, Ellen Dalen, et al.
Publicado: (2021)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

Smallest detectable differences in clinical variables related to temporomandibular joint arthritis in juvenile idiopathic arthritis
por: Stoustrup, Peter, et al.
Publicado: (2011)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

Impact of physiotherapy on orofacial manifestations of juvenile idiopathic arthritis
por: Vassis, Stratos, et al.
Publicado: (2023)

Pain experience in children with juvenile idiopathic arthritis on TNFalpha-inhibitors
por: Jeppesen, JH, et al.
Publicado: (2008)

Effect of infliximab in sweet’s syndrome-pyoderma gangraenosum overlap syndrome
por: Mahler, Birgitte, et al.
Publicado: (2014)

Mandibular distraction osteogenesis in patients with unilateral TMJ involvement in juvenile idiopathic arthritis
por: Nørholt, SE, et al.
Publicado: (2011)

Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
por: Arnstad, Ellen Dalen, et al.
Publicado: (2020)

Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children
por: Kyvsgaard, Nini, et al.
Publicado: (2019)

Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
por: Remesal, A, et al.
Publicado: (2011)

Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
por: Murias, S, et al.
Publicado: (2011)

Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus‐Based Recommendations
por: Stoustrup, Peter, et al.
Publicado: (2022)

Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms
por: Stoustrup, Peter, et al.
Publicado: (2015)

Generalized pustular psoriasis in infant with heterozygous mutation in the IL36RN gene successfully treated with infliximab
por: Glerup, Mia, et al.
Publicado: (2014)

Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: a study of feasibility and preliminary efficacy
por: Lomholt, Johanne Jeppesen, et al.
Publicado: (2015)

Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
por: Peltoniemi, Suvi Oili Orvokki, et al.
Publicado: (2023)

Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
por: Kyvsgaard, Nini, et al.
Publicado: (2021)

Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study
por: Rahimi, Hanna, et al.
Publicado: (2018)

Prognostic factors for the disease course and 8-year outcome in Nordic children with oligoarticular-onset juvenile idiopathic arthritis
por: Peltoniemi, Suvi, et al.
Publicado: (2014)

Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2020)

Joint cartilage thickness and automated determination of bone age and bone health in juvenile idiopathic arthritis
por: Twilt, Marinka, et al.
Publicado: (2017)

Impact of biologics on growth in children with juvenile idiopathic arthritis
por: Uettwiller, F, et al.
Publicado: (2011)

Joint cartilage thickness measured by ultrasound in juvenile idiopathic arthritis
por: Pradsgaard, D, et al.
Publicado: (2012)

Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
por: Foell, Dirk, et al.
Publicado: (2023)

Assessment of dentofacial growth deviation in juvenile idiopathic arthritis: Reliability and validity of three-dimensional morphometric measures
por: Stoustrup, Peter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e19dj2dslbgv9icgluki5imh9s